Clinical Trials · NCT01605136
Phase III Confirmatory Study in Erythropoietic Protoporphyria
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 93
- Start date
- May 2012
- Locations
- 7 sites, United States
- Primary endpoint
- Duration of Direct Sunlight Exposure Between 10:00 and 18:00 Hours on Days When no Pain Was Experienced (Pain Score of 0).